Darinaparsin: Phase II started

Solasia began an open-label, Asian Phase II trial to evaluate 300 mg/m 2

Read the full 133 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE